Am J Surg

1. MARSHALL TE, Ibrahim R, Lee-Saxton YJ, Tumati A, et al
   Disparities in postoperative adjuvant therapy utilization and factors impacting survival among anaplastic thyroid cancer patients.
   Am J Surg. 2024;238:115944.
   

   >> Share

   
   
2. COGUA LM, Tupper CJ, Silberstein PT, Coan KE, et al
   Intermediate-sized follicular thyroid cancer surgical trends before and after the 2015 American thyroid association guideline changes.
   Am J Surg. 2024;238:115830.
   

   >> Share

   
   
3. BARRIO MJ, Pozdeyev N, Raeburn CD, McIntyre RC Jr, et al
   Pre-operative thyroglobulin measurement for thyroid cancer risk of recurrence and response to therapy.
   Am J Surg. 2024;238:115818.
   

   >> Share

   
   

   
   Ann Otol Rhinol Laryngol

4. LIANG S, Bellamkonda N, Tullis B, Hunt JP, et al
   Superselective Versus Selective Neck Dissection in the Treatment of Papillary Thyroid Carcinoma.
   Ann Otol Rhinol Laryngol. 2024 Nov 27:34894241302142.
   

   >> Share

   
   

   
   BMC Cancer

5. ZHANG L, Wang S, Wang L
   SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma.
   BMC Cancer. 2024;24:1480.
   

   >> Share

   
   
6. KASMANN L, Nieto A, Rennollet R, Gurtner R, et al
   Validation of two predictive models for survival in anaplastic thyroid cancer (ATC).
   BMC Cancer. 2024;24:1477.
   

   >> Share

   
   

   
   BMC Surg

7. HA LN, Phuong NT, Son MH
   The impact of qualitative [18F]FDG PET/CT in predicting clinical outcomes of post-surgical differentiated thyroid cancer patients with elevated thyroglobulin and negative radioiodine whole-body scan.
   BMC Surg. 2024;24:377.
   

   >> Share

   
   
8. CHEN ZX, Zhao XR, Deng JM, Cao Y, et al
   Cumulative sum analysis for evaluating learning curve of endoscopic lateral neck dissection.
   BMC Surg. 2024;24:375.
   

   >> Share

   
   

   
   Cancer

9. NIERENGARTEN MB
   First person profile: Quynh-Thu Le, MD: Dr Le confronts the difficult challenges of improving the efficacy and safety of radiation therapy in the treatment of head and neck cancers.
   Cancer. 2024;130:4164.
   

   >> Share

   
   
10. DAY AT, Mitchell DN, Eary RL, Jones E, et al
    Considerations in screening for asymptomatic carotid artery stenosis in irradiated head and neck cancer survivors.
    Cancer. 2024 Nov 26. doi: 10.1002/cncr.35639.
    

    >> Share

    
    

    
    Clin Cancer Res

11. JOHNSON FM, O'Hara MP, Yapindi L, Jiang P, et al
    Phase 1/2 Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas.
    Clin Cancer Res. 2024 Nov 26. doi: 10.1158/1078-0432.CCR-24-2290.
    

    >> Share

    
    
12. MASTROLONARDO EV, Nunes KL, Llerena P, Nikitina A, et al
    Response-Adaptive Surgical Timing in neoadjuvant immunotherapy demonstrates enhanced pathologic treatment response in Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2024 Nov 25. doi: 10.1158/1078-0432.CCR-24-0037.
    

    >> Share

    
    

    
    Clin Nucl Med

13. FENG Y, Lan X, Zhang X
    131I Accumulation Due to an Intrauterine Device in a Papillary Thyroid Carcinoma Patient.
    Clin Nucl Med. 2024 Nov 27. doi: 10.1097/RLU.0000000000005597.
    

    >> Share

    
    

    
    Dis Esophagus

14. CHEN J, Wang Z, Huang J, Zhang Y, et al
    Experimental study on radiational characteristics and nursing care of a novel radioisotope 188Re memory alloy esophageal stent.
    Dis Esophagus. 2024;37:doae088.
    

    >> Share

    
    
15. MINAKATA N, Kadota T, Sakashita S, Inaba A, et al
    Tumor thickness is associated with metastasis in patients with submucosal invasive adenocarcinoma of the esophagogastric junction.
    Dis Esophagus. 2024;37:doae083.
    

    >> Share

    
    
16. MOONS J, Declerck H, Gijbels E, Jans M, et al
    Evaluation of patient satisfaction with an enhanced recovery protocol for esophageal resections: a concurrent quantitative and qualitative analysis.
    Dis Esophagus. 2024;37:doae079.
    

    >> Share

    
    
17. DONATO BB, Campany ME, Brady JT, Jenkins JA, et al
    Complete pathologic response in esophageal adenocarcinoma: does it make a difference?
    Dis Esophagus. 2024;37:doae068.
    

    >> Share

    
    
18. ROSMOLEN WD, Pouw RE, Bergman JJ, Sprangers MAG, et al
    Reasons for fear of cancer recurrence after endoscopic treatment of T1 esophageal adenocarcinoma. A semi-structured interview study.
    Dis Esophagus. 2024;37:doae067.
    

    >> Share

    
    

    
    Head Neck

19. YAN S, Zhang P, Tan S, Mo H, et al
    LncRNA SNHG14 Facilitates Cisplatin Resistance Through Upregulating Notch2 via Binding to U2AF2 in Nasopharyngeal Carcinoma.
    Head Neck. 2024 Nov 27. doi: 10.1002/hed.28016.
    

    >> Share

    
    
20. ANSARI E, Minulina NC, van Beers MA, van Es RJJ, et al
    Low Skeletal Muscle Mass: A Strong Predictive Factor for Surgical Complications After Free Forearm Flap Reconstruction in Oral Cancer Patients.
    Head Neck. 2024 Nov 27. doi: 10.1002/hed.28014.
    

    >> Share

    
    
21. XIAO JB, Cherukupalli A, Tran KL, Prisman E, et al
    Predictors of Gastrostomy Tube Placement in Head and Neck Cancer Patients Undergoing Radiation or Chemoradiotherapy: A Systematic Review.
    Head Neck. 2024 Nov 25. doi: 10.1002/hed.28010.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

22. THARIAT J, Bosset M, Falcoz A, Vernerey D, et al
    Survival without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial in Head and Neck Cancer Patients with Oligometastases using Stereotactic Ablative Radiotherapy (SABR)-alone or chemotherapy SABR.
    Int J Radiat Oncol Biol Phys. 2024 Nov 27:S0360-3016(24)03651.
    

    >> Share

    
    

    
    J Clin Oncol

23. NICHOLS AC, Theurer J, Prisman E, Read N, et al
    Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial.
    J Clin Oncol. 2024;42:4023-4028.
    

    >> Share

    
    

    
    J Laryngol Otol

24. LAU KL, Ferozepurwalla Z
    Spontaneous regression of head and neck squamous cell carcinoma: a systematic review and meta-analysis of case reports.
    J Laryngol Otol. 2024 Nov 25:1-7. doi: 10.1017/S0022215124001336.
    

    >> Share

    
    

    
    J Oral Maxillofac Surg

25. MISHRA A, Nair RR, Vijay S, Attakkil A, et al
    A Comparative Study of Speech and Swallowing Postoperative Outcomes in Oral Cancer: Impact of Lateral Mandibular Continuity Restoration.
    J Oral Maxillofac Surg. 2024 Nov 1:S0278-2391(24)00916.
    

    >> Share

    
    

    
    Oral Oncol

26. KORIC A, Chang CP, Hu S, Snyder J, et al
    Oral health-related quality of life among oropharyngeal cancer survivors.
    Oral Oncol. 2024;159:107062.
    

    >> Share

    
    
27. BOZKURT G, Turri Zanoni M, Ferrari M, Ioppi A, et al
    Salvage surgery in nasopharyngeal Cancer: Unraveling the efficacy of transnasal endoscopic nasopharyngectomy for advanced stage recurrent tumors.
    Oral Oncol. 2024;159:107048.
    

    >> Share

    
    
28. LIAN H, Hua Y, Paka Lubamba G, Zhang G, et al
    Reconstruction of extensive lower lip defects using vascularized mucosal flap with external skin complex tissue.
    Oral Oncol. 2024;159:107056.
    

    >> Share

    
    
29. KIM JY, Kim Y, Kim EH, Chung MK, et al
    Initial negative resection margin versus revised negative resection margin in patients who underwent surgery without adjuvant therapy for early-stage oral tongue squamous cell carcinoma.
    Oral Oncol. 2024;159:107046.
    

    >> Share

    
    
30. LYU W, Gong J, Zhu L, Xu T, et al
    MR radiomics unveils neoadjuvant chemo-responsiveness with insights into selective treatment de-intensification in HPV-positive oropharyngeal carcinoma.
    Oral Oncol. 2024;159:107049.
    

    >> Share

    
    
31. PEREZ-DE-OLIVEIRA ME, Wagner VP, Bingle CD, Vargas PA, et al
    Disruption of oncogenic pathways in mucoepidermoid carcinoma: CREB inhibitor 666.15 as a potential therapeutic agent.
    Oral Oncol. 2024;159:107029.
    

    >> Share

    
    
32. AL AFIF A, Rosen P, Gardella J, Norwood TG, et al
    Predicting outcomes in head and neck surgery with modified frailty index and surgical apgar scores.
    Oral Oncol. 2024;159:107045.
    

    >> Share

    
    
33. MAHTO K, Kumar Goldar G, Varshney A, Malhotra M, et al
    Achieving negative superficial resection margins with NBI and white light in carcinoma oral cavity: Could it be a norm?
    Oral Oncol. 2024;159:107044.
    

    >> Share

    
    
34. MA L, Li C
    Da Vinci robot-assisted surgery for deep lobe of parotid benign tumor via retroauricular hairline approach: Exploration of a new surgical method for parotid tumors.
    Oral Oncol. 2024;159:107043.
    

    >> Share

    
    
35. HUANG NS, Chen JY, Meng Y, Li QL, et al
    Pralsetinib as neoadjuvant therapy for RET-Altered differentiated thyroid cancer: Two case reports.
    Oral Oncol. 2024;159:107014.
    

    >> Share

    
    
36. DANIELS KE, Awad DR, Liu SX, Mocharnuk J, et al
    Impact of post-operative transoral robotic surgery hemorrhage on adjuvant treatment delays in patients with oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2024;159:107031.
    

    >> Share

    
    
37. GREEN L, McDowell L, Ip F, Tapia M, et al
    Early return to work is possible after transoral robotic surgery (TORS) in carefully selected patients with oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2024;159:107032.
    

    >> Share

    
    
38. LU YT, Lin CW, Su SC, Ho YT, et al
    L48H37, a curcumin analog, suppresses matrix metalloproteinase-9 expression and activity to hamper nasopharyngeal cancer cell migration.
    Oral Oncol. 2024;159:107038.
    

    >> Share

    
    
39. STAIBANO P, Au M, Xie M, Gupta MK, et al
    Return to work and self-reported swallowing following transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma: A retrospective cohort study.
    Oral Oncol. 2024;159:107033.
    

    >> Share

    
    
40. CLEERE EF, Hintze JM, Doherty C, Timon CVI, et al
    The association of frailty with morbidity and mortality following major mucosal head and neck surgery.
    Oral Oncol. 2024;159:107021.
    

    >> Share

    
    
41. MARRET G, Lamy C, Vacher S, Cabel L, et al
    Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA.
    Oral Oncol. 2024;160:107111.
    

    >> Share

    
    
42. JEYARAJ G
    Letter to the editor, "Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancer.".
    Oral Oncol. 2024;160:107092.
    

    >> Share

    
    
43. LIU Y, Fu N, Liu H, Su S, et al
    Risk factors of lymph node metastasis in the diffuse sclerosing variant of papillary thyroid carcinoma compared with conventional papillary thyroidcarcinoma in pediatric populations.
    Oral Oncol. 2024;160:107120.
    

    >> Share

    
    
44. YAN C, Wang R, Zhang C, Lin G, et al
    Induction chemotherapy for locally advanced nasopharyngeal carcinoma: Efficacy and safety of the TPC regimen compared to GP and TPF.
    Oral Oncol. 2024;160:107119.
    

    >> Share

    
    
45. ESPEROUZ F, Caponio VCA, Santarelli A, Ballini A, et al
    Are we ready to use ultrasounds in the clinical assessment of depth of invasion and tumor thickness in oral squamous cell carcinoma? Results from a systematic review, meta-analysis and trial sequential analysis.
    Oral Oncol. 2024;159:107104.
    

    >> Share

    
    
46. PANG P, Xue X, Xu Z, Duan W, et al
    Functional reconstruction of lip defects.
    Oral Oncol. 2024;159:107055.
    

    >> Share

    
    
47. VON WITZLEBEN A, Grages A, Thomas J, Ezic J, et al
    Immune checkpoint expression on tumor-infiltrating lymphocytes (TIL) is dependent on HPV status in oropharyngeal carcinoma (OPSCC) - A single-cell RNA sequencing analysis.
    Oral Oncol. 2024;159:107107.
    

    >> Share

    
    
48. GENSTERBLUM-MILLER E, Bhangale A, Majid DA, Pienkowski VM, et al
    Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma.
    Oral Oncol. 2024;159:107108.
    

    >> Share

    
    
49. SANKAR GANESH P, Naseef Pathoor N, Kanna Gopal R
    Letter to the editor regarding, "Impact of post-operative transoral robotic surgery hemorrhage on adjuvant treatment delays in patients with oropharyngeal squamous cell carcinoma".
    Oral Oncol. 2024;159:107091.
    

    >> Share

    
    
50. VIEIRA SH, Vidoris AAC, Matos LL
    Metastasis to the ciliary body and iris from a parotid carcinoma.
    Oral Oncol. 2024;159:107098.
    

    >> Share

    
    
51. PENG H, Zhang LY, Zhu WZ, Zhou Y, et al
    Innovative use of radial artery retrograde forearm flap for oral and maxillofacial reconstruction.
    Oral Oncol. 2024;159:107084.
    

    >> Share

    
    
52. MORGENTHALER J, Trommer M, Khor R, Wada M, et al
    Can we safely de-escalate HPV(+) oropharyngeal cancers? - A review of current practices and novel approaches.
    Oral Oncol. 2024;159:107089.
    

    >> Share

    
    
53. WANG X, Chen X, Mei Z
    Changes of immune function mediated by Gasdermin-E in the immune microenvironment of primary oral squamous cell carcinoma.
    Oral Oncol. 2024;159:107088.
    

    >> Share

    
    
54. RITSCHL LM, Sackerer V, Pippich K, Zink JK, et al
    Impact of tumor localization and choice of microvascular flap on posterior airway changes following ablative surgery in primary oral squamous cell carcinoma: A monocentric cross-sectional study.
    Oral Oncol. 2024;159:107080.
    

    >> Share

    
    
55. KLIBNGERN H, Kang CJ, Lee LY, Ng SH, et al
    Margin-to-depth ratio as an independent prognostic factor in resected oral cavity squamous cell carcinoma: A nationwide cohort study.
    Oral Oncol. 2024;159:107102.
    

    >> Share

    
    
56. NIELSEN SB, Holm Larsen MH, Channir HI, Kiss K, et al
    The value of tongue base mucosectomy in the work-up of squamous cell carcinoma of unknown primary: A Danish national cohort study.
    Oral Oncol. 2024;159:107083.
    

    >> Share

    
    
57. VILLARME A, Ebran N, Pace-Loscos T, Schiappa R, et al
    Prognostic impact of intra tumoral HPV-16 viral load in oropharyngeal squamous cell carcinomas.
    Oral Oncol. 2024;159:107082.
    

    >> Share

    
    
58. PELAEZ-PRESTEL HF, Gonzalez-Martin F, Ras-Carmona A, Rocha A, et al
    Oral squamous cell carcinomas drive monocytes into immunosuppressive CD25(+)CD163(+)CD206(+) macrophages.
    Oral Oncol. 2024;159:107078.
    

    >> Share

    
    
59. POISSONNET V, Chabrillac E, Uro-Coste E, Woisard V, et al
    Therapeutic strategy for advanced stages salivary carcinomas of the tongue: A multicenter REFCOR study.
    Oral Oncol. 2024;159:107072.
    

    >> Share

    
    
60. ICHIMURA N, Urata Y, Kobayashi T, Ebata R, et al
    Mutational landscape of Japanese patients with oral squamous cell carcinoma from comprehensive genomic profiling tests.
    Oral Oncol. 2024;159:107079.
    

    >> Share

    
    
61. DE BIASIO MJ, Mohan R, Hendler A, Jillian Tsai C, et al
    Lymphatic mapping in second primary or recurrent oral cavity cancer with prior neck treatment: A case series and scoping review.
    Oral Oncol. 2024;159:107077.
    

    >> Share

    
    
62. HARRIS MK, Dang S, Smith JD, Chinn S, et al
    Bivalirudin for unsalvageable venous congestion or obstruction in head and neck free flap reconstruction.
    Oral Oncol. 2024;159:107076.
    

    >> Share

    
    
63. BALAJI H, Aithal VU, Varghese JJ, Devaraja K, et al
    Agreement between patient-reported and clinician-rated speech and swallowing outcomes - Understanding the trend in post-operative oral cavity cancer patients.
    Oral Oncol. 2024;159:107068.
    

    >> Share

    
    
64. BALAGURU L, Hanubal KS, Galochkina Z, Lee JH, et al
    Surgical and functional outcomes after salvage oropharyngectomy.
    Oral Oncol. 2024;159:107050.
    

    >> Share

    
    
65. HEFT NEAL ME, Smith JD, Lyden TH, Chanowski EJP, et al
    Oral cavity obliteration is a novel predictor of functional outcomes after glossectomy reconstruction.
    Oral Oncol. 2024;159:107058.
    

    >> Share

    
    

    
    Otolaryngol Head Neck Surg

66. AHN S, Oh EJ, Saleem MI, Tham T, et al
    Machine Learning Methods in Classification of Prolonged Radiation Therapy in Oropharyngeal Cancer: National Cancer Database.
    Otolaryngol Head Neck Surg. 2024;171:1764-1772.
    

    >> Share

    
    
67. WANG J, Tharakan T, Jackson RS, Puram SV, et al
    Chimeric Versus Multiple Simultaneous Free Flaps for Head and Neck Reconstruction.
    Otolaryngol Head Neck Surg. 2024;171:1697-1704.
    

    >> Share

    
    
68. BHATT N, Yang J, DeBaere L, Wang RS, et al
    Reducing Length of Stay in Reconstructive Head and Neck Surgery Patients: A Quality Improvement Initiative.
    Otolaryngol Head Neck Surg. 2024;171:1938-1948.
    

    >> Share

    
    
69. TIRELLI G, Gardenal N, Polesel J, De Groodt J, et al
    Palatoglossus Muscle and T4 Category in the Eighth Edition of TNM Staging System for OPSCC.
    Otolaryngol Head Neck Surg. 2024;171:1792-1797.
    

    >> Share

    
    
70. SHARMA RK, Upton M, Vaidya AU, Longino ES, et al
    Cost-Effectiveness Analysis of Operating Room and In-Office Reconstruction of Skin Cancer Defects.
    Otolaryngol Head Neck Surg. 2024;171:1715-1720.
    

    >> Share

    
    
71. GILJA S, Kumar A, Londino AV 3rd, Kirke DN, et al
    Pathologic Characteristics and Surgical Outcomes of Pediatric Versus Adult Well-Differentiated Thyroid Cancer.
    Otolaryngol Head Neck Surg. 2024;171:1682-1689.
    

    >> Share

    
    

    
    PLoS One

72. TAMURA K, Takenaka Y, Hosokawa K, Sato T, et al
    Effect of immortal time bias on the association between immune-related adverse events and oncological outcomes following immune checkpoint inhibitors therapy for head and neck squamous cell carcinoma.
    PLoS One. 2024;19:e0314209.
    

    >> Share

    
    

    
    Radiother Oncol

73. LI R, Zhao Y, Wu K, Li H, et al
    p16 status or response to induction chemotherapy, which predicts survival outcomes in Chinese oropharyngeal cancer treated with definitive radiotherapy?
    Radiother Oncol. 2024;201:110578.
    

    >> Share

    
    
74. OUD M, Breedveld S, Gizynska M, Chen YH, et al
    Dosimetric advantages of adaptive IMPT vs. Enhanced workload and treatment time - A need for automation.
    Radiother Oncol. 2024;201:110548.
    

    >> Share

    
    
75. GUINOT JL, Bacorro W, Budrukkar A, Bussu F, et al
    GEC-ESTRO recommendations for head & neck cancer brachytherapy (interventional radiotherapy): 2nd update with focus on HDR and PDR.
    Radiother Oncol. 2024;201:110533.
    

    >> Share

    
    
76. WU CN, Wang JD, Chen WC, Lin CY, et al
    Intensity-modulated proton therapy versus volumetric-modulated ARC therapy in patients with nasopharyngeal carcinoma: A long-term, multicenter cohort study.
    Radiother Oncol. 2024 Nov 23:110648. doi: 10.1016/j.radonc.2024.110648.
    

    >> Share

    
    
77. JIMENEZ-LABAIG P, Aymerich C, Rullan A, Cacicedo J, et al
    Prevalence of depressive and anxiety symptoms in patients with head and neck cancer undergoing radiotherapy: A systematic review and meta-analysis of longitudinal studies.
    Radiother Oncol. 2024;202:110649.
    

    >> Share

    
    
78. LIU M, Pang B, Chen S, Zeng Y, et al
    Deep learning-based multiple-CT optimization: An adaptive treatment planning approach to account for anatomical changes in intensity-modulated proton therapy for head and neck cancers.
    Radiother Oncol. 2024;202:110650.
    

    >> Share

    
    
79. URSINO S, Malfatti G, Felice F, Bonomo P, et al
    Deglutition preservation after swallowing (Swoars)-sparing IMRT in head and neck cancers: Definitive results of A multicenter prospective study of the italian association of radiotherapy and clinical oncology (Airo).
    Radiother Oncol. 2024 Nov 22:110651. doi: 10.1016/j.radonc.2024.110651.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share